How Much Does Peptide Therapy Cost?

Peptide therapy costs typically include several components: an initial consultation, lab work, the peptides themselves, follow-up visits, and supplies such as syringes and bacteriostatic water. Initial consultations with a peptide-specialized physician or clinic generally range from $150 to $400, depending on location and provider credentials.

Lab work is usually required before starting therapy to establish baseline hormone levels, metabolic markers, and organ function. A standard panel may cost $200-$500 out of pocket, though many insurance plans cover routine blood work. Some clinics include initial labs in their consultation fee.

The peptides themselves represent the largest ongoing expense. Monthly costs for a single peptide typically range from $150 to $500 when obtained through a compounding pharmacy with a prescription. FDA-approved peptides like semaglutide or tesamorelin can cost significantly more, sometimes exceeding $1,000-$1,500 per month without insurance.

Follow-up appointments are usually scheduled every 4-12 weeks and cost $75-$200 per visit. Supplies (insulin syringes, alcohol swabs, bacteriostatic water) add roughly $20-$40 per month. In total, most patients should expect to spend between $300 and $800 per month for a single-peptide protocol through a legitimate medical provider.

Several factors influence total cost. Geographic location matters: clinics in major metropolitan areas like New York, Los Angeles, or Miami tend to charge 20-40% more than providers in smaller cities or rural areas. Telehealth providers have introduced more competitive pricing by reducing overhead.

The type of peptide has the largest impact on per-unit cost. Compounded peptides like BPC-157, CJC-1295, or Ipamorelin are relatively affordable because they are synthesized by compounding pharmacies. FDA-approved brand-name drugs like Wegovy (semaglutide) or Egrifta (tesamorelin) carry pharmaceutical pricing that reflects R&D costs, patent protection, and manufacturer margins.

Dosing frequency and duration also affect cost. A peptide taken daily (like tesamorelin) will cost more per month than one taken 2-3 times per week. Longer treatment durations may qualify for package pricing at some clinics. Peptide stacks involving two or more compounds multiply costs proportionally.

Provider type influences pricing as well. Anti-aging and functional medicine clinics may charge premium consultation fees but sometimes offer bundled pricing. Direct-to-consumer telehealth platforms often have lower consultation fees but may charge more for the peptides. Compounding pharmacy pricing varies significantly, so shopping around can yield meaningful savings.

Insurance coverage for peptide therapy is limited but not nonexistent. FDA-approved peptides prescribed for their indicated uses are most likely to receive coverage. Semaglutide for type 2 diabetes (Ozempic) and tesamorelin for HIV-associated lipodystrophy (Egrifta) are covered by many commercial insurance plans and Medicare Part D.

However, off-label uses are rarely covered. If a physician prescribes semaglutide for weight loss but the patient does not meet the BMI criteria required by their insurer, the claim will likely be denied. Prior authorization is often required even for on-label prescriptions, adding administrative burden.

Compounded peptides are almost never covered by insurance because they are not FDA-approved products. This means the most commonly used research peptides (BPC-157, CJC-1295, Ipamorelin, GHK-Cu) will be entirely out-of-pocket expenses.

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can sometimes be used for peptide therapy if it is prescribed by a licensed provider for a qualifying medical condition. Check with your plan administrator, as rules vary. Some patients also use medical credit services like CareCredit to finance longer treatment courses.

Growth-hormone peptides (CJC-1295, Ipamorelin, Sermorelin) generally cost $150-$350 per month through compounding pharmacies. These are among the most affordable peptides and are widely available.

Healing peptides (BPC-157, TB-500) typically cost $100-$300 per month. BPC-157 is one of the most affordable peptides on the market. Oral BPC-157 capsules are also available, often at a lower cost than injectable forms, though bioavailability differences exist.

Weight-loss peptides vary the most in price. Compounded semaglutide or tirzepatide can cost $300-$600 per month through a compounding pharmacy, while brand-name versions (Wegovy, Zepbound) list at $1,000-$1,500 per month without insurance. AOD-9604 and tesofensine are more affordable at $150-$300 per month.

Anti-aging peptides (Epitalon, GHK-Cu, FOXO4-DRI) range from $150 to $500 per month. GHK-Cu is also available in topical formulations that may be less expensive than injectable forms. Epitalon protocols are often cyclical (10-20 days on, then off), which reduces average monthly cost.

Cognitive peptides (Semax, Selank) are among the most affordable at $50-$150 per month, partly because they are administered intranasally in small quantities.

Several strategies can help manage peptide therapy costs without compromising quality or safety. First, compare pricing across multiple compounding pharmacies. Prices for the same peptide can vary by 30-50% between pharmacies, and some offer discount programs for recurring orders.

Consider telehealth providers, which typically have lower consultation fees ($75-$150 vs $200-$400 for in-person visits) and may partner with compounding pharmacies that offer competitive pricing. Some platforms bundle consultation, labs, and peptides into a single monthly fee.

Ask about package pricing or loyalty discounts. Many clinics offer reduced rates for 3-month or 6-month commitments. Some compounding pharmacies provide auto-ship discounts of 10-15%.

Time your lab work strategically. If your insurance covers annual wellness labs, coordinate with your peptide provider to include relevant markers (IGF-1, metabolic panel, hormones) in that covered blood draw rather than paying for separate testing.

Finally, be cautious about extremely cheap peptides from unregulated sources. While the cost savings may be tempting, peptides from non-reputable suppliers may be under-dosed, contaminated, or degraded. The cost of adverse health effects from poor-quality products far exceeds any savings on purchase price.